Decision of the EEA Joint Committee No 166/2021 of 11 June 2021 amending Annex II... (22024D0166)
EU - Internationale Abkommen
2024/166
1.2.2024

DECISION OF THE EEA JOINT COMMITTEE No 166/2021

of 11 June 2021

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/166]

THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,
Whereas:
(1) Commission Implementing Regulation (EU) 2021/50 of 22 January 2021 authorising an extension of use and a change in the specifications of the novel food ‘2′-fucosyllactose/difucosyllactose mixture’ and amending Implementing Regulation (EU) 2017/2470  ( 1 ) is to be incorporated into the EEA Agreement.
(2) Commission Implementing Regulation (EU) 2021/51 of 22 January 2021 authorising a change of the conditions of use of the novel food ‘ trans -resveratrol’ under Regulation (EU) 2015/2283 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) 2017/2470  ( 2 ) is to be incorporated into the EEA Agreement.
(3) Commission Implementing Regulation (EU) 2021/82 of 27 January 2021 authorising the placing on the market of 6’-sialyllactose sodium salt as a novel food under Regulation (EU) 2015/2283 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) 2017/2470  ( 3 ) is to be incorporated into the EEA Agreement.
(4) Commission Implementing Regulation (EU) 2021/96 of 28 January 2021 authorising the placing on the market of 3'-sialyllactose sodium salt as a novel food under Regulation (EU) 2015/2283 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) 2017/2470  ( 4 ) is to be incorporated into the EEA Agreement.
(5) Commission Implementing Regulation (EU) 2021/120 of 2 February 2021 authorising the placing on the market of partially defatted rapeseed powder from Brassica rapa L. and Brassica napus L. as a novel food under Regulation (EU) 2015/2283 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) 2017/2470  ( 5 ) is to be incorporated into the EEA Agreement.
(6) This Decision concerns legislation regarding foodstuffs. Legislation regarding foodstuffs shall not apply to Liechtenstein as long as the application of the Agreement between the European Community and the Swiss Confederation on trade in agricultural products is extended to Liechtenstein, as specified in the introduction to Chapter XII of Annex II to the EEA Agreement. This Decision is therefore not to apply to Liechtenstein.
(7) Annex II to the EEA Agreement should therefore be amended accordingly,
HAS ADOPTED THIS DECISION:

Article 1

Chapter XII of Annex II to the EEA Agreement shall be amended as follows:
1.
The following indents are added in point 124b (Commission Implementing Regulation (EU) 2017/2470):
‘-
32021 R 0050 : Commission Implementing Regulation (EU) 2021/50 of 22 January 2021 ( OJ L 23, 25.1.2021, p. 7 ),
- 32021 R 0051 : Commission Implementing Regulation (EU) 2021/51 of 22 January 2021 ( OJ L 23, 25.1.2021, p. 10 ),
- 32021 R 0082 : Commission Implementing Regulation (EU) 2021/82 of 27 January 2021 ( OJ L 29, 28.1.2021, p. 16 ),
- 32021 R 0096 : Commission Implementing Regulation (EU) 2021/96 of 28 January 2021 ( OJ L 31, 29.1.2021, p. 201 ),
- 32021 R 0120 : Commission Implementing Regulation (EU) 2021/120 of 2 February 2021 ( OJ L 37, 3.2.2021, p. 1 ).’
2.
The following points are inserted after point 187 (Commission Implementing Regulation (EU) 2020/1634):
‘188.
32021 R 0050 : Commission Implementing Regulation (EU) 2021/50 of 22 January 2021 authorising an extension of use and a change in the specifications of the novel food ‘2′-fucosyllactose/difucosyllactose mixture’ and amending Implementing Regulation (EU) 2017/2470 ( OJ L 23, 25.1.2021, p. 7 ).
189.
32021 R 0051 : Commission Implementing Regulation (EU) 2021/51 of 22 January 2021 authorising a change of the conditions of use of the novel food ‘ trans -resveratrol’ under Regulation (EU) 2015/2283 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) 2017/2470 ( OJ L 23, 25.1.2021, p. 10 ).
190.
32021 R 0082 : Commission Implementing Regulation (EU) 2021/82 of 27 January 2021 authorising the placing on the market of 6’-sialyllactose sodium salt as a novel food under Regulation (EU) 2015/2283 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) 2017/2470 ( OJ L 29, 28.1.2021, p. 16 ).
191.
32021 R 0096 : Commission Implementing Regulation (EU) 2021/96 of 28 January 2021 authorising the placing on the market of 3'-sialyllactose sodium salt as a novel food under Regulation (EU) 2015/2283 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) 2017/2470 ( OJ L 31, 29.1.2021, p. 201 ).
192.
32021 R 0120 : Commission Implementing Regulation (EU) 2021/120 of 2 February 2021 authorising the placing on the market of partially defatted rapeseed powder from Brassica rapa L. and Brassica napus L. as a novel food under Regulation (EU) 2015/2283 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) 2017/2470 ( OJ L 37, 3.2.2021, p. 1 ).’

Article 2

The texts of Implementing Regulations (EU) 2021/50, (EU) 2021/51, (EU) 2021/82, (EU) 2021/96 and (EU) 2021/120 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union , shall be authentic.

Article 3

This Decision shall enter into force on 12 June 2021, provided that all the notifications under Article 103(1) of the EEA Agreement have been made  ( *1 ) .

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union .
Done at Brussels, 11 June 2021.
For the EEA Joint Committee
The President
Clara GANSLANDT
( 1 )    OJ L 23, 25.1.2021, p. 7 .
( 2 )    OJ L 23, 25.1.2021, p. 10 .
( 3 )    OJ L 29, 28.1.2021, p. 16 .
( 4 )    OJ L 31, 29.1.2021, p. 201 .
( 5 )    OJ L 37, 3.2.2021, p. 1 .
( *1 )   No constitutional requirements indicated.
ELI: http://data.europa.eu/eli/dec/2024/166/oj
ISSN 1977-0677 (electronic edition)
Markierungen
Leseansicht